NYSEHealth Care

Charles River Laboratories

CRL

Revenue

$4.1B

EPS

9.27

FY2025 summary

Charles River Laboratories reported revenue of $4.13 billion in 2025, marking a growth of nearly 4% from the previous year. The company's net income was $474.6 million, with a profit margin of over 11%. Each share earned $9.27 during this period.

·Revenue: $4,129,409,000
·Net Income: $474,624,000
·Profit Margin: 11.5%

Revenue

Net income

Revenue growth (YoY)

Profit margin